{"id":"https://openalex.org/W2563539445","doi":"https://doi.org/10.1016/s1525-0016(16)33403-7","title":"595. Enhanced Liver Transduction and Efficient Protection from Pre-Existing Neutralizing Antibodies with Exosome-Associated AAV8 Vectors","display_name":"595. Enhanced Liver Transduction and Efficient Protection from Pre-Existing Neutralizing Antibodies with Exosome-Associated AAV8 Vectors","publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2563539445","doi":"https://doi.org/10.1016/s1525-0016(16)33403-7","mag":"2563539445"},"language":"en","primary_location":{"id":"doi:10.1016/s1525-0016(16)33403-7","doi":"https://doi.org/10.1016/s1525-0016(16)33403-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33403-7","pdf_url":"http://www.cell.com/article/S1525001616334037/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001616334037/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004654525","display_name":"Amine Meliani","orcid":"https://orcid.org/0000-0001-8704-7546","observed_orcids":["https://orcid.org/0000-0001-8704-7546"]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Amine Meliani","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110461261","display_name":"Zachary Fitzpatrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zachary Fitzpatrick","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111705886","display_name":"Florence Boisg\u00e9rault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Boisgerault","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045686507","display_name":"Giuseppe Ronzitti","orcid":"https://orcid.org/0000-0002-9184-0210","observed_orcids":["https://orcid.org/0000-0002-9184-0210"]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Giuseppe Ronzitti","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044917645","display_name":"Fanny Collaud","orcid":"https://orcid.org/0000-0002-2901-7290","observed_orcids":["https://orcid.org/0000-0002-2901-7290"]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fanny Collaud","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005915776","display_name":"S\u00e9verine Charles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Severine Charles","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064371575","display_name":"Casey A. Maguire","orcid":"https://orcid.org/0000-0001-8681-5179","observed_orcids":["https://orcid.org/0000-0001-8681-5179"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Casey A Maguire","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049298836","display_name":"Federico Mingozzi","orcid":"https://orcid.org/0000-0003-0685-3752","observed_orcids":["https://orcid.org/0000-0003-0685-3752","https://orcid.org/0000-0002-6607-0058","https://orcid.org/0009-0002-9658-6466"]},"institutions":[{"id":"https://openalex.org/I4210127167","display_name":"Genethon (France)","ror":"https://ror.org/03fj96t64","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210127167"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Federico Mingozzi","raw_affiliation_strings":["Genethon, Evry, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genethon, Evry, France","institution_ids":["https://openalex.org/I4210127167"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12099496,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":null,"first_page":"S235","last_page":"S236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adeno-associated-virus-vectors","display_name":"adeno-associated virus vectors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/aav8","display_name":"AAV8","score":0.9890000224113464},{"id":"https://openalex.org/keywords/exosomes","display_name":"exosomes","score":0.9350000023841858},{"id":"https://openalex.org/keywords/liver-transduction","display_name":"liver transduction","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hepatocyte-targeting","display_name":"hepatocyte targeting","score":0.8130000233650208},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9020000100135803},{"id":"https://openalex.org/keywords/humoral-immune-response","display_name":"humoral immune response","score":0.8709999918937683},{"id":"https://openalex.org/keywords/in-vivo-gene-transfer","display_name":"in vivo gene delivery","score":0.718999981880188}],"concepts":[{"id":"https://openalex.org/C15152581","wikidata":"https://www.wikidata.org/wiki/Q7833966","display_name":"Transduction (biophysics)","level":2,"score":0.8582066297531128},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.7370115518569946},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6469380259513855},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6336920857429504},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5883889198303223},{"id":"https://openalex.org/C2781261824","wikidata":"https://www.wikidata.org/wiki/Q903634","display_name":"Exosome","level":5,"score":0.576922595500946},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.567924439907074},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5407474040985107},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.5337451696395874},{"id":"https://openalex.org/C2778107364","wikidata":"https://www.wikidata.org/wiki/Q355989","display_name":"Adeno-associated virus","level":5,"score":0.42505767941474915},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.42152881622314453},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41428178548812866},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.37755098938941956},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.37738537788391113},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.3337811827659607},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3280217945575714},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.16600185632705688},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.07372868061065674},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1525-0016(16)33403-7","doi":"https://doi.org/10.1016/s1525-0016(16)33403-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33403-7","pdf_url":"http://www.cell.com/article/S1525001616334037/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/s1525-0016(16)33403-7","doi":"https://doi.org/10.1016/s1525-0016(16)33403-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1525-0016(16)33403-7","pdf_url":"http://www.cell.com/article/S1525001616334037/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2563539445.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2793421058","https://openalex.org/W2563210205","https://openalex.org/W2770755929","https://openalex.org/W2765408594","https://openalex.org/W168143921","https://openalex.org/W4226054387","https://openalex.org/W2150447973","https://openalex.org/W2735234748","https://openalex.org/W2551929485","https://openalex.org/W2058864263"],"abstract_inverted_index":{"Adeno-associated":[0],"virus":[1],"(AAV)":[2],"based":[3],"vectors":[4,38],"are":[5,39],"ideal":[6],"tools":[7],"for":[8],"in":[9,24,29],"vivo":[10,25],"gene":[11],"transfer.":[12],"The":[13],"excellent":[14],"safety":[15],"profile":[16],"and":[17,33,50],"the":[18,73],"highly":[19],"efficient":[20],"targeting":[21],"of":[22,58,66],"hepatocytes":[23],"have":[26],"been":[27],"demonstrated":[28],"both":[30,48],"preclinical":[31],"studies":[32],"clinical":[34],"trials.":[35],"Although":[36],"AAV":[37,82],"not":[40],"strongly":[41],"immunogenic,":[42],"they":[43],"can":[44,77],"give":[45],"rise":[46],"to":[47,60],"cellular":[49],"humoral":[51],"immune":[52],"responses.":[53],"Additionally,":[54],"as":[55],"a":[56],"result":[57],"exposure":[59],"wild-type":[61],"AAV,":[62],"an":[63],"important":[64],"fraction":[65],"humans":[67],"harbor":[68],"pre-existing":[69],"neutralizing":[70],"antibodies":[71],"against":[72],"viral":[74],"capsid,":[75],"which":[76],"prevent":[78],"successful":[79],"transduction":[80],"by":[81],"vectors.":[83]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2017-01-06T00:00:00"}